New patent for Progenics Pharms drug PYLARIFY

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for PYLARIFY
Annual Drug Patent Expirations for PYLARIFY

Pylarify is a drug marketed by Progenics Pharms Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has seventy-four patent family members in twenty-three countries.

The generic ingredient in PYLARIFY is piflufolastat f-18. One supplier is listed for this compound. Additional details are available on the piflufolastat f-18 profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top